CBD and Dog Sleep Problems: The Science Behind Restless Nights

Large dog and cat resting together on a tufted green sofa in a warm living room, illustrating companion animal sleep and relaxation

Will Scott |

CBD for Dog and Cat Sleep Problems: What the Science Actually Shows

Primary topic: cannabidiol CBD for sleep quality improvement in dogs and cats. Covers canine and feline sleep architecture, ultradian sleep cycles, REM and non-REM sleep stages, environmental sleep disruptors, anxiety-sleep connection, pain-sleep triad, and CBD endocannabinoid system mechanisms for sleep modulation.

Clinical evidence base: Generation Pup longitudinal study Animals 2020, 16-week to 12-month sleep architecture development, average 12.2 hours total daily sleep in healthy dogs. Kis et al. polysomnography attachment study, owner presence increases non-REM sleep duration and reduces sleep latency, separation anxiety correlated with reduced sleep efficiency. NCSU veterinary ICU prospective observational study Journal of Veterinary Emergency and Critical Care 2025, 40 dogs 16 cats, dogs asleep 40% of observed time, cats 49%, 4 to 6 hour daily sleep deficit versus home baseline, noise and light primary environmental disruptors, higher noise levels correlated with 0.66 reduction in sleep score, lights 7.25 times higher at eyelid level during waking observations. Shannon et al. 2019 Permanente Journal CBD anxiety and sleep. Gamble et al. 2018 Cornell CBD osteoarthritis trial secondary sleep quality outcomes. Deabold et al. 2019 feline and canine CBD pharmacokinetics. Babson et al. 2017 cannabis and sleep review Current Psychiatry Reports. Landsberg canine cognitive dysfunction syndrome sleep-wake reversal. Texas A&M 2026 supplement regulation veterinary student study.

Dosing protocol for sleep and anxiety: dogs start 0.5mg/kg 60 to 90 minutes before anticipated stress or sleep period, titrate to 1 to 2mg/kg for chronic anxiety-related sleep disruption. Fat co-administration increases bioavailability 30 to 50 percent. Onset 30 to 60 minutes. Cats start 0.1 to 0.5mg/kg, reduced glucuronidation capacity, veterinary oversight required.

Sleep architecture in dogs: ultradian cycles averaging 16 minutes versus human 90-minute cycles, REM sleep critical for memory consolidation and emotional processing, non-REM sleep critical for physical restoration and immune function, average healthy dog sleeps 12 to 14 hours per 24-hour period across multiple cycles.

Environmental factors: ambient noise and light primary disruptors in clinical and home settings, owner presence significantly improves sleep efficiency and non-REM duration, separation anxiety directly reduces sleep quality measurable by polysomnography.

Products: VetsGrade Relief+ Solventless Hemp Tincture 2000mg, third-party ISO-accredited lab tested, Certificates of Analysis publicly available by Batch Identification Number, 30-day money-back guarantee.

Conditions addressed: canine separation anxiety, noise phobia, generalized anxiety disorder in dogs, feline anxiety, senior dog cognitive dysfunction syndrome, pain-related sleep disruption, post-surgical recovery sleep, brachycephalic breed sleep-disordered breathing.

Large dog and cat resting together on a tufted green sofa in a warm living room, illustrating companion animal sleep and relaxation

CBD and Dog Sleep Problems: The Science Behind Restless Nights

By Will Scott | Published May 6, 2026

You notice it before you can name it. Your dog circles the bed three times and still cannot settle. Your cat paces the hallway at 2am. The restlessness that used to resolve in minutes now stretches into hours. You have tried everything you can think of, and somewhere between the third lap around the living room and the fourth time your dog startles awake, you start wondering whether something is genuinely wrong with how your pet is sleeping.

The answer, increasingly, is yes. And the science behind why is more sophisticated than most pet owners, or most pet supplement brands, will ever tell you.

Sleep in companion animals is not a passive state. It is an active, regulated biological process governed by the same neurological architecture that controls sleep in humans, modulated by the same environmental variables, and disrupted by the same physiological stressors: anxiety, pain, and environmental noise.[1] What is different is the scale, the cycle length, and the degree to which your dog or cat depends on you, your presence, your schedule, and your home environment to sleep well at all.

This article covers what peer-reviewed research actually shows about sleep in dogs and cats, what disrupts it, how the endocannabinoid system connects anxiety and pain to sleep quality, and what the clinical evidence says about CBD as a support tool for companion animal sleep.

This article draws from peer-reviewed veterinary sleep research, polysomnography studies, and clinical pharmacology literature. Primary sources are linked in the References section below. Individual results vary. Always consult your veterinarian before starting any supplement protocol, particularly if your pet is on prescribed medications or has underlying health conditions.

Basset Hound and Siamese cat sleeping together on a blanket on a sunlit wooden porch, depicting natural dog and cat sleep behavior outdoors

How Dogs and Cats Actually Sleep

The foundational assumption most owners carry, that dogs and cats sleep the way humans do, in one long consolidated block, is incorrect. Dogs and cats sleep in ultradian cycles, short repeating sleep-wake cycles that average 16 minutes in dogs compared to the 90-minute cycles of human sleep.[2] A healthy adult dog sleeps between 12 and 14 hours per 24-hour period, distributed across multiple cycles throughout the day and night. Cats sleep even more, averaging 12 to 16 hours depending on age, activity level, and environment.

The Generation Pup longitudinal study, published in Animals in 2020 and tracking dogs from 16 weeks through 12 months of age, documented average total daily sleep of 12.2 hours in young dogs, with daytime sleep averaging 7.0 hours and nighttime sleep averaging 7.3 hours.[3] By 12 months, daytime sleep decreased significantly as dogs became more active and socially engaged, while nighttime sleep consolidated. The most common sleeping position at 12 months was stretched out on the side, observed in 84.2% of dogs, a posture associated with deep relaxation and thermal comfort.

Within each sleep cycle, dogs and cats cycle through the same fundamental stages as humans: wakefulness, drowsiness, non-REM sleep, and REM sleep.[4] Non-REM sleep is the physically restorative stage, during which tissue repair, immune function, and metabolic restoration occur. REM sleep is the neurologically active stage, during which memory consolidation, emotional processing, and learning integration take place. Research by Kis et al. confirmed that dogs experience genuine REM sleep with the same EEG signatures observed in human REM, including rapid eye movements, muscle atonia, and characteristic theta wave activity.[5]

What this means practically is that a dog or cat who appears to be sleeping but is cycling through shallow drowsiness without reaching non-REM or REM stages is not getting restorative sleep. The animal looks rested. It is not.

What Disrupts Sleep in Dogs and Cats

A 2025 prospective observational study from North Carolina State University College of Veterinary Medicine, published in the Journal of Veterinary Emergency and Critical Care, provides the most quantified data available on environmental sleep disruption in companion animals.[6] The study observed 40 dogs and 16 cats in a veterinary ICU over a 4-week period, recording sleep state, ambient noise, light levels, number of people present, and time of day at hourly intervals.

The findings are striking. Dogs in the ICU were observed to be asleep only 40% of the time. Cats were asleep 49% of the time. Both figures represent a deficit of 4 to 6 hours of daily sleep compared to healthy home baselines documented in longitudinal studies.[3,6] The primary drivers of this deficit were measurable and specific.

Higher noise levels correlated with a 0.66 reduction in sleep score across all observations. Light levels at the eyelid were 7.25 times higher during waking observations than during sleeping observations, confirming that brightness directly suppressed sleep onset. The number of people present in the environment was inversely correlated with sleep probability. Observations between 9pm and 6am showed significantly more sleep than daytime hours, consistent with the circadian preference for darkness and quiet.[6]

The ICU findings translate directly to home environments. A dog sleeping in a bright room with ambient television noise, irregular human foot traffic, and inconsistent overnight schedules is experiencing the same category of environmental sleep disruption documented in the clinical setting. The stressors are lower in magnitude but identical in mechanism. Noise, light, and unpredictable human activity suppress sleep onset and reduce non-REM duration in companion animals regardless of the setting.

The Anxiety-Sleep Connection in Dogs and Cats

Anxiety and sleep disruption in companion animals are not separate problems. They are the same problem expressed through two different observable behaviors. The polysomnography research by Kis et al. demonstrated this connection with measurable precision.[5] Dogs whose owners were present during sleep showed significantly shorter sleep latency (time to fall asleep), longer non-REM sleep duration, and higher overall sleep efficiency compared to dogs whose owners were absent. The Pet Attachment Questionnaire score correlated directly with the magnitude of sleep benefit from owner presence. Dogs with higher attachment scores gained more sleep quality improvement from co-sleeping than dogs with lower attachment scores.

The inverse is equally documented. Dogs with separation anxiety and avoidance behaviors showed measurably worse sleep macrostructure across every variable. The anxiety was not just behavioral. It was neurological, producing EEG-measurable changes in sleep architecture that persisted even when the dog appeared to be resting.[5]

The Generation Pup study found that 29.8% of owners reported their dog dreams a lot, and 33.7% reported their dog stops breathing sometimes during sleep, suggesting that sleep-disordered breathing and REM behavior events are far more common in the companion animal population than clinical diagnosis rates would suggest.[3] Brachycephalic breeds showed the highest rates of sleep-disordered breathing, with French Bulldogs at 100% snoring prevalence and Pugs at 66.7%, both associated with documented reductions in sleep quality and oxygen saturation during sleep.[3]

Basset Hound and Siamese cat sleeping together on a blanket on a sunlit wooden porch, depicting natural dog and cat sleep behavior outdoors

Senior Dogs, Cognitive Dysfunction, and Sleep-Wake Reversal

Canine cognitive dysfunction syndrome (CDS), the veterinary equivalent of Alzheimer's disease, affects an estimated 14 to 35% of dogs over age 8 and up to 68% of dogs over age 15.[7] One of its most consistent and distressing clinical signs is sleep-wake cycle reversal: the dog sleeps during the day and is restless, disoriented, and vocal at night. This is not a behavioral problem. It is a neurological one, driven by progressive deterioration of the suprachiasmatic nucleus, the brain's circadian pacemaker, and declining melatonin production with age.[7]

The Dog Aging Project cohort study, analyzing 43,517 dogs, found that older dogs received significantly more supplements than younger dogs, with orthopedic and neurological conditions representing the highest supplement use categories.[8] Senior dogs with CDS represent one of the highest-need, lowest-served populations in companion animal wellness. The content available to owners of these dogs is almost entirely anecdotal. The clinical research is not.

Infographic showing the pain-sleep triad in dogs: a self-reinforcing cycle of chronic pain, anxiety, and sleep disruption with fragmented rest

The Pain-Sleep Triad

Pain, anxiety, and sleep disruption form a self-reinforcing triad in companion animals that is well-documented in veterinary behavioral science but rarely addressed as a unified clinical target.[9] Dogs with chronic orthopedic pain sleep poorly because pain signals interrupt non-REM sleep cycles. Poor sleep elevates cortisol, which increases pain sensitivity and anxiety. Elevated anxiety further disrupts sleep onset and reduces non-REM duration. The cycle compounds over weeks and months, producing a dog who appears chronically fatigued, irritable, and increasingly reactive, symptoms that owners frequently attribute to aging rather than to a treatable physiological cascade.

The Gamble et al. 2018 Cornell University randomized controlled trial on CBD and osteoarthritis in dogs reported not only statistically significant reductions in pain scores and improvements in mobility, but owner-reported improvements in overall quality of life that included rest and sleep behavior as secondary outcomes.[10] Breaking the pain component of the triad with CBD produced downstream improvements in the anxiety and sleep components without targeting them directly.

How CBD Affects Sleep in Dogs and Cats

CBD does not induce sleep the way a sedative does. It does not suppress the central nervous system or produce unconsciousness. What it does is address the physiological conditions that prevent sleep from occurring naturally, through three distinct but complementary mechanisms.[11]

First, CBD inhibits the enzyme FAAH, which breaks down anandamide, the endogenous cannabinoid associated with calm, reward, and emotional regulation. By increasing circulating anandamide, CBD reduces the neurological arousal state that keeps anxious dogs in a hypervigilant waking state when their environment signals safety.[12] This is the mechanism most directly relevant to anxiety-related sleep disruption.

Second, CBD modulates serotonin receptor activity, specifically at the 5-HT1A receptor, which is involved in regulating mood, anxiety, and the transition between wakefulness and sleep.[13] Shannon et al. 2019, in a review published in The Permanente Journal, found that CBD demonstrated significant potential in reducing anxiety scores and improving sleep quality scores in a human clinical population, with 79.2% of subjects reporting decreased anxiety and 66.7% reporting improved sleep within the first month.[14] While this study was conducted in humans, the 5-HT1A receptor mechanism is conserved across mammalian species, making the finding pharmacologically relevant to companion animals.

Third, CBD's anti-inflammatory and analgesic activity at CB2 receptors and TRPV1 channels reduces the pain signaling that interrupts non-REM sleep cycles in dogs with orthopedic conditions, intervertebral disc disease, and post-surgical recovery.[10] By reducing the pain component of the sleep-anxiety-pain triad, CBD allows the sleep architecture to normalize without requiring direct sedation.

Babson et al. 2017, in a review published in Current Psychiatry Reports, examined the existing literature on cannabinoids and sleep across multiple species and concluded that CBD specifically, as distinct from THC, showed the most consistent evidence for improving sleep quality without the REM suppression associated with THC and many pharmaceutical sleep aids.[15] REM suppression is a significant concern in companion animals because REM sleep is critical for memory consolidation and emotional regulation, both of which are already compromised in anxious and cognitively declining dogs.

Dosing: Timing Is the Variable Most Brands Ignore

For sleep and anxiety-related sleep disruption in dogs, the timing of CBD administration is as important as the dose. Because oral CBD in a tincture reaches peak plasma concentration at approximately 90 minutes post-administration, with onset of effect beginning at 30 to 60 minutes, the dose should be administered 60 to 90 minutes before the anticipated stress event or sleep period.[16]

For dogs with generalized anxiety-related sleep disruption, starting at 0.5mg/kg once daily in the evening and titrating to 1 to 2mg/kg over two to four weeks is consistent with the clinical evidence base. For acute situational anxiety, such as thunderstorms, fireworks, or travel, a single dose of 1 to 2mg/kg administered 60 to 90 minutes before the event is appropriate.[10]

Fat co-administration is not optional. The pharmacokinetic research by Bartner et al. and Deabold et al. both confirmed that CBD bioavailability increases by 30 to 50% when administered with food containing fat.[16,17] A dose given on an empty stomach may not reach therapeutic plasma concentrations regardless of the milligram amount. Administer Relief+ with a small amount of food, a treat, or directly onto a fat-containing meal.

For cats, the reduced glucuronidation capacity of feline hepatic metabolism requires lower starting doses of 0.1 to 0.5mg/kg and slower titration over four to six weeks.[17] Veterinary oversight is particularly important for cats given the metabolic differences and the limited feline-specific pharmacokinetic data currently available.

Full therapeutic benefit for chronic anxiety-related sleep disruption requires two to four weeks of consistent daily dosing as the endocannabinoid system reaches a new homeostatic baseline. Owners who administer CBD once and observe no change are not giving the compound sufficient time to demonstrate its effect on the underlying neurological state.

Female laboratory scientist in white coat and safety glasses examining a small amber CBD tincture bottle under laboratory conditions, representing third-party testing and quality verification for pet CBD products

What to Look for in a Pet CBD Product for Sleep and Anxiety

The supplement market under DSHEA allows manufacturers to imply sleep and anxiety benefits without clinical proof, without disclosing extraction methods, and without testing for residual solvents.[18] A 2026 study from Texas A&M University found that 15% of final-year veterinary students incorrectly believed supplements are regulated the same way as pharmaceutical drugs.[19] The gap between what a label implies and what a product contains is not hypothetical. It is the architecture of the regulatory framework the entire category operates within.

The markers that distinguish a product with genuine therapeutic potential are specific and verifiable. Third-party Certificates of Analysis from an ISO-accredited laboratory confirm cannabinoid potency, terpene profile, and the absence of pesticides, heavy metals, and residual solvents. Full-spectrum solventless extract preserves the entourage effect, including the terpene linalool, which has documented anxiolytic activity, and beta-caryophyllene, which has documented CB2 agonist and anti-inflammatory activity, both directly relevant to the anxiety-sleep-pain triad.[11] Vet-informed formulation means the dosing guidance reflects companion animal pharmacokinetics, not human supplement logic applied to a different species.

VetsGrade Relief+ Solventless Tincture is formulated specifically for dogs and cats using solventless full-spectrum rosin extract, third-party tested by an ISO-accredited laboratory, with every Certificate of Analysis publicly available by Batch Identification Number. For senior dogs with cognitive dysfunction and sleep-wake reversal, pairing Relief+ with consistent environmental management, reduced overnight light and noise, and a fixed sleep schedule addresses both the neurological and environmental components of the disruption simultaneously. Every VetsGrade product is backed by a 30-day money-back guarantee.

Frequently Asked Questions

For anxiety-related sleep disruption, start at 0.5mg/kg once daily in the evening and titrate to 1 to 2mg/kg over two to four weeks.[10] Administer 60 to 90 minutes before the anticipated sleep period to align with peak plasma concentration timing. Always give with food containing fat to maximize bioavailability. Consult your veterinarian before starting CBD if your dog is on concurrent medications.

Nighttime restlessness in dogs has several documented causes. In senior dogs over age 8, canine cognitive dysfunction syndrome is a primary cause, producing sleep-wake cycle reversal driven by deterioration of the brain's circadian pacemaker and declining melatonin production.[7] In younger dogs, anxiety, pain, and environmental factors including noise and light are the most common drivers. A veterinary evaluation is appropriate for any dog with persistent nighttime restlessness to rule out pain and neurological causes before starting a supplement protocol.

For acute situational anxiety, onset of effect begins within 30 to 60 minutes of administration. For chronic anxiety-related sleep disruption, consistent daily dosing for two to four weeks is required before full therapeutic benefit is apparent as the endocannabinoid system reaches a new homeostatic baseline.[12] Owners who discontinue after a single dose or a few days are not giving the compound sufficient time to demonstrate its effect on the underlying neurological state.

CBD does not induce sleep through sedation. It does not suppress the central nervous system or produce unconsciousness. It addresses the physiological conditions that prevent natural sleep from occurring, primarily anxiety and pain, through endocannabinoid system modulation.[11] At therapeutic doses, some dogs may appear more relaxed or calm, which owners sometimes interpret as drowsiness. This is distinct from pharmaceutical sedation and does not impair normal waking function.

Cats have reduced glucuronidation capacity compared to dogs, affecting how they metabolize many compounds.[17] Lower starting doses of 0.1 to 0.5mg/kg and slower titration over four to six weeks are appropriate. The feline research base for CBD is more limited than the canine base. Veterinary oversight is particularly important for cats, especially those on concurrent medications or with underlying health conditions.

The NCSU veterinary ICU study identified ambient noise and light as the two primary environmental disruptors of sleep in companion animals, with higher noise levels correlating with a 0.66 reduction in sleep score and light levels 7.25 times higher during waking observations than sleeping observations.[6] Practical interventions include reducing overnight ambient noise, dimming or eliminating light sources in the sleep area, maintaining a consistent sleep schedule, and ensuring owner presence or a familiar scent during the sleep period. The polysomnography research confirmed that owner presence significantly improves non-REM sleep duration and reduces sleep latency in dogs.[5]

CBD modulates the 5-HT1A serotonin receptor, which regulates mood, anxiety, and the transition between wakefulness and sleep.[13] It also inhibits FAAH, increasing circulating anandamide, which reduces the neurological arousal state that keeps anxious dogs hypervigilant during periods of owner absence.[12] Polysomnography research confirmed that separation anxiety produces measurable EEG-level changes in sleep architecture, not just behavioral restlessness. CBD addresses the neurological component of this disruption rather than masking the behavioral symptoms.

Solventless full-spectrum CBD preserves the complete terpene profile of the source material, including linalool, which has documented anxiolytic activity, and beta-caryophyllene, which has documented CB2 agonist and anti-inflammatory activity.[11] These terpenes contribute to the entourage effect, the synergistic interaction between cannabinoids and terpenes that produces superior therapeutic outcomes compared to CBD isolate. For anxiety and sleep specifically, the full terpene profile is pharmacologically relevant, not a marketing distinction. Solventless extraction also eliminates residual solvent risk entirely, which matters for a product administered daily to a companion animal.

References

Peer-reviewed veterinary sleep research, polysomnography studies, and clinical pharmacology literature cited in this article.

  1. Arand D, Bonnet M. Sleep deprivation. In: Kryger M, Roth T, Dement W, eds. Principles and Practice of Sleep Medicine. 5th ed. Elsevier; 2011:67-75.
  2. Zepelin H, Siegel JM, Tobler I. Mammalian sleep. In: Kryger M, Roth T, Dement W, eds. Principles and Practice of Sleep Medicine. 4th ed. Elsevier; 2005:91-100.
  3. Kinsman R, Owczarczak-Garstecka S, Casey R, et al. Sleep and physical activity levels in pet dogs: a longitudinal study. Animals (Basel). 2020;10(7):1177. [Generation Pup]
  4. Mondino A, Nettifee J, Muñana K. An exploratory study on the relationship between idiopathic epilepsy and sleep in dogs. J Vet Intern Med. 2025;39:e70026.
  5. Kis A, Gácsi M, Topál J, et al. Sleep in the dog: comparative, behavioral and translational relevance. Current Opinion in Behavioral Sciences. 2020;33:25-33.
  6. Devereux EA, Viana AV, Lynch AM, Gruen ME, Lafuente SF, Schaff VF. Factors affecting sleep among dogs and cats in a veterinary intensive care unit. J Vet Emerg Crit Care. 2025;35:226-232.
  7. Landsberg GM, Nichol J, Araujo JA. Cognitive dysfunction syndrome: a disease of canine and feline brain aging. Vet Clin North Am Small Anim Pract. 2012;42(4):749-768.
  8. Mundell L, et al. Prevalence and patterns of supplement use in companion dogs: findings from the Dog Aging Project. Am J Vet Res. 2024.
  9. Mathews K, Kronen PW, Lascelles D, et al. Guidelines for recognition, assessment and treatment of pain. J Small Anim Pract. 2014;55(6):E10-68.
  10. Gamble LJ, Boesch JM, Frye CW, et al. Pharmacokinetics, safety, and clinical efficacy of cannabidiol treatment in osteoarthritic dogs. Front Vet Sci. 2018;5:165.
  11. Russo EB. Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol. 2011;163(7):1344-1364.
  12. Pacher P, Batkai S, Kunos G. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev. 2006;58(3):389-462.
  13. Blessing EM, Steenkamp MM, Manzanares J, Marmar CR. Cannabidiol as a potential treatment for anxiety disorders. Neurotherapeutics. 2015;12(4):825-836.
  14. Shannon S, Lewis N, Lee H, Hughes S. Cannabidiol in anxiety and sleep: a large case series. Perm J. 2019;23:18-041.
  15. Babson KA, Sottile J, Morabito D. Cannabis, cannabinoids, and sleep: a review of the literature. Curr Psychiatry Rep. 2017;19(4):23.
  16. Bartner LR, McGrath S, Rao S, Hyatt LK, Wittenburg LA. Pharmacokinetics of cannabidiol administered by 3 delivery methods at 2 different dosages to healthy dogs. Can J Vet Res. 2018;82(3):178-183.
  17. Deabold KA, Schwark WS, Wolf L, Wakshlag JJ. Single-dose pharmacokinetics and preliminary safety assessment with use of CBD-rich hemp nutraceutical in healthy dogs and cats. Animals (Basel). 2019;9(10):832.
  18. U.S. Food and Drug Administration. Dietary Supplement Health and Education Act of 1994. fda.gov/food/dietary-supplements
  19. Gallagher B, et al. Veterinary student and public perceptions of supplement versus medication regulation in companion animals. J Vet Pharmacol Ther. 2026.

Disclaimer: This article is for educational purposes only and is not intended to replace professional veterinary advice, diagnosis, or treatment. VetsGrade products are not FDA-approved drugs and are not intended to diagnose, treat, cure, or prevent any disease or condition in animals. Always consult your veterinarian before starting CBD, particularly if your pet is on prescribed medications or has underlying health conditions. Individual results vary. The clinical studies cited represent population-level findings and are not guarantees for any individual animal.